Intuitive Surgical (NASDAQ: ISRG) shares preliminary Q4 and 2025 results

Rhea-AI Filing Summary

Intuitive Surgical, Inc. furnished a report stating that it has issued a press release with unaudited preliminary financial results for the fourth quarter and full year 2025. The release is provided as Exhibit 99.1.

The company also supplied additional unaudited preliminary revenue and procedure information in tabular form as Exhibit 99.2, which has been posted to the Investor Relations section of its website. The materials are designated as furnished rather than filed, meaning they are not subject to certain Exchange Act liabilities or automatically incorporated into other securities law filings.

0001035267false00010352672026-01-142026-01-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported): January 14, 2026

INTUITIVE SURGICAL, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-30713

77-0416458

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

1020 Kifer Road

Sunnyvale, California 94086

(Address of principal executive offices) (zip code)

   Registrant’s telephone number, including area code: (408) 523-2100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

ISRG

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  

Item 2.02. Results of Operations and Financial Condition.

On January 14, 2026, Intuitive Surgical, Inc. (“Intuitive”) issued a press release announcing certain unaudited preliminary fourth quarter and full year 2025 financial results. A copy of the press release is furnished hereto as Exhibit 99.1.

Additional unaudited preliminary revenue and procedure information is provided in the tables attached hereto as Exhibit 99.2, which has also been posted to the Investor Relations section of the Intuitive website at: https://isrg.gcs-web.com/.

The information in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of Intuitive under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are furnished with this report on Form 8-K:

Exhibit No.

Description

99.1

Press release issued by Intuitive Surgical, Inc., dated January 14, 2026.

99.2

Unaudited preliminary revenue and procedure information, as of January 14, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INTUITIVE SURGICAL, INC.

Date: January 14, 2026

By:

/s/ JAMIE E. SAMATH

Name: Jamie E. Samath

Title: Executive Vice President, Chief Financial Officer

FAQ

What did Intuitive Surgical (ISRG) disclose in this 8-K filing?

Intuitive Surgical disclosed that it issued a press release with unaudited preliminary financial results for the fourth quarter and full year 2025 and furnished this release as Exhibit 99.1.

Which periods do Intuitive Surgical's preliminary results in this filing cover?

The unaudited preliminary results described in the exhibits cover fourth quarter 2025 and full year 2025 financial performance.

What additional data did Intuitive Surgical (ISRG) provide besides the press release?

The company provided additional unaudited preliminary revenue and procedure information in tables furnished as Exhibit 99.2.

Where can investors find the detailed revenue and procedure tables for Intuitive Surgical?

The revenue and procedure tables in Exhibit 99.2 have also been posted on the Investor Relations section of Intuitive Surgical’s website at the URL given in the filing.

Are the preliminary 2025 results in this Intuitive Surgical filing audited?

No. The filing describes the fourth quarter and full year 2025 figures as unaudited preliminary financial results and data.

Are Intuitive Surgical’s Exhibits 99.1 and 99.2 considered filed or furnished?

The filing states that the information in this report, including Exhibits 99.1 and 99.2, is furnished and not deemed filed for purposes of Section 18 of the Exchange Act.